Article Versions Notes

Liu Y-H, Chen L-C, Cheng W-T, Wei P-S, Hsieh C-M, Sheu M-T, Lin S-Y, Ho H-O, Lin H-L. Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer. Pharmaceutics. 2023; 15(2):473. https://doi.org/10.3390/pharmaceutics15020473

Liu, Yu-Hsuan, Ling-Chun Chen, Wen-Ting Cheng, Pu-Sheng Wei, Chien-Ming Hsieh, Ming-Thau Sheu, Shyr-Yi Lin, Hsiu-O Ho, and Hong-Liang Lin. 2023. "Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer" Pharmaceutics 15, no. 2: 473. https://doi.org/10.3390/pharmaceutics15020473

Liu, Y.-H., Chen, L.-C., Cheng, W.-T., Wei, P.-S., Hsieh, C.-M., Sheu, M.-T., Lin, S.-Y., Ho, H.-O., & Lin, H.-L. (2023). Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer. Pharmaceutics, 15(2), 473. https://doi.org/10.3390/pharmaceutics15020473